Cargando…

Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities

BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Germaine, Howard, Kirsten, Chapman, Jeremy R., Chadban, Steven, Cross, Nicholas, Tong, Allison, Webster, Angela C., Craig, Jonathan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261160/
https://www.ncbi.nlm.nih.gov/pubmed/22279541
http://dx.doi.org/10.1371/journal.pone.0029591
_version_ 1782221562120765440
author Wong, Germaine
Howard, Kirsten
Chapman, Jeremy R.
Chadban, Steven
Cross, Nicholas
Tong, Allison
Webster, Angela C.
Craig, Jonathan C.
author_facet Wong, Germaine
Howard, Kirsten
Chapman, Jeremy R.
Chadban, Steven
Cross, Nicholas
Tong, Allison
Webster, Angela C.
Craig, Jonathan C.
author_sort Wong, Germaine
collection PubMed
description BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities. METHODS: A probabilistic Markov model was constructed, using current outcomes for patients with defined co-morbidities treated with either dialysis or transplantation, to compare the health and economic benefits of listing and transplantation with dialysis. FINDINGS: Using the current waiting time for deceased donor transplantation, transplanting a potential recipient, with or without co-morbidities achieves survival gains of between 6 months and more than three life years compared to remaining on dialysis, with an average incremental cost-effectiveness ratio (ICER) of less than $50,000/LYS, even among those with advanced age. Age at listing and the waiting time for transplantation are the most influential variables within the model. If there were an unlimited supply of organs and no waiting time, transplanting the younger and healthier individuals saves the most number of life years and is cost-saving, whereas transplanting the middle-age to older patients still achieves substantial incremental gains in life expectancy compared to being on dialysis. CONCLUSIONS: Our modelled analyses suggest transplanting the younger and healthier individuals with end-stage kidney disease maximises survival gains and saves money. Listing and transplanting those with considerable co-morbidities is also cost-effective and achieves substantial survival gains compared with the dialysis alternative. Preferentially excluding the older and sicker individuals cannot be justified on utilitarian grounds.
format Online
Article
Text
id pubmed-3261160
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32611602012-01-25 Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities Wong, Germaine Howard, Kirsten Chapman, Jeremy R. Chadban, Steven Cross, Nicholas Tong, Allison Webster, Angela C. Craig, Jonathan C. PLoS One Research Article BACKGROUND: Deceased donor kidneys for transplantation are in most countries allocated preferentially to recipients who have limited co-morbidities. Little is known about the incremental health and economic gain from transplanting those with co-morbidities compared to remaining on dialysis. The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities. METHODS: A probabilistic Markov model was constructed, using current outcomes for patients with defined co-morbidities treated with either dialysis or transplantation, to compare the health and economic benefits of listing and transplantation with dialysis. FINDINGS: Using the current waiting time for deceased donor transplantation, transplanting a potential recipient, with or without co-morbidities achieves survival gains of between 6 months and more than three life years compared to remaining on dialysis, with an average incremental cost-effectiveness ratio (ICER) of less than $50,000/LYS, even among those with advanced age. Age at listing and the waiting time for transplantation are the most influential variables within the model. If there were an unlimited supply of organs and no waiting time, transplanting the younger and healthier individuals saves the most number of life years and is cost-saving, whereas transplanting the middle-age to older patients still achieves substantial incremental gains in life expectancy compared to being on dialysis. CONCLUSIONS: Our modelled analyses suggest transplanting the younger and healthier individuals with end-stage kidney disease maximises survival gains and saves money. Listing and transplanting those with considerable co-morbidities is also cost-effective and achieves substantial survival gains compared with the dialysis alternative. Preferentially excluding the older and sicker individuals cannot be justified on utilitarian grounds. Public Library of Science 2012-01-18 /pmc/articles/PMC3261160/ /pubmed/22279541 http://dx.doi.org/10.1371/journal.pone.0029591 Text en Wong et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wong, Germaine
Howard, Kirsten
Chapman, Jeremy R.
Chadban, Steven
Cross, Nicholas
Tong, Allison
Webster, Angela C.
Craig, Jonathan C.
Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title_full Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title_fullStr Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title_full_unstemmed Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title_short Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
title_sort comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261160/
https://www.ncbi.nlm.nih.gov/pubmed/22279541
http://dx.doi.org/10.1371/journal.pone.0029591
work_keys_str_mv AT wonggermaine comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT howardkirsten comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT chapmanjeremyr comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT chadbansteven comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT crossnicholas comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT tongallison comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT websterangelac comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities
AT craigjonathanc comparativesurvivalandeconomicbenefitsofdeceaseddonorkidneytransplantationanddialysisinpeoplewithvaryingagesandcomorbidities